Helmi Khadra1, Mohamed Bakeer2, Adam Hauch1, Tian Hu3, Emad Kandil1. 1. Division of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA. 2. Department of Surgery, Louisiana State University School of Medicine, New Orleans, LA, USA. 3. Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Abstract
BACKGROUND: Several reports have proposed that increased vascular flow on color Doppler sonography may be associated with malignancy in thyroid nodules. Others have described no correlation between the presence of flow and risk of malignancy. The purpose of this study was to determine whether the vascularity of a thyroid nodule can aid in the prediction of malignancy by performing a meta-analysis of the current literature. METHODS: Independent reviewers conducted a systematic review of publications from PubMed, EMBASE, and the Cochrane Database of Systematic Review using the following keyword searches: "vascular thyroid nodule", and "vascular malignant thyroid nodule". Outcomes included vascular flow pattern, nodule size, calcifications, echogenicity, margins, and shape. Data were extracted following review of appropriate studies, and outcome differences were calculated using analysis of variance and the Bonferroni method. RESULTS: Eighty-nine publications were identified and 14 prospective studies met inclusion criteria totaling 4,154 thyroid nodules, 1,419 (34%) of which were malignant. Thirty-three percent of malignant thyroid nodules had no vascular flow, while 17% had peripheral and 50% had internal vascular flow. There was no significant difference in vascular flow (95% CI: -14.329, 4.257), or peripheral vascular flow rate between malignant and benign thyroid nodules (95% CI: -29.254, 4.313). Also, there was no significant difference in internal vascularity between malignant and benign thyroid nodules (95% CI: -72.067, 2.824). CONCLUSIONS: It appears that utilization of vascular flow on color Doppler sonography may not accurately predict malignancy in thyroid nodules. Further studies are warranted to investigate the predictive role of increased vascularity in diagnosing suspicious thyroid nodules.
BACKGROUND: Several reports have proposed that increased vascular flow on color Doppler sonography may be associated with malignancy in thyroid nodules. Others have described no correlation between the presence of flow and risk of malignancy. The purpose of this study was to determine whether the vascularity of a thyroid nodule can aid in the prediction of malignancy by performing a meta-analysis of the current literature. METHODS: Independent reviewers conducted a systematic review of publications from PubMed, EMBASE, and the Cochrane Database of Systematic Review using the following keyword searches: "vascular thyroid nodule", and "vascular malignant thyroid nodule". Outcomes included vascular flow pattern, nodule size, calcifications, echogenicity, margins, and shape. Data were extracted following review of appropriate studies, and outcome differences were calculated using analysis of variance and the Bonferroni method. RESULTS: Eighty-nine publications were identified and 14 prospective studies met inclusion criteria totaling 4,154 thyroid nodules, 1,419 (34%) of which were malignant. Thirty-three percent of malignant thyroid nodules had no vascular flow, while 17% had peripheral and 50% had internal vascular flow. There was no significant difference in vascular flow (95% CI: -14.329, 4.257), or peripheral vascular flow rate between malignant and benign thyroid nodules (95% CI: -29.254, 4.313). Also, there was no significant difference in internal vascularity between malignant and benign thyroid nodules (95% CI: -72.067, 2.824). CONCLUSIONS: It appears that utilization of vascular flow on color Doppler sonography may not accurately predict malignancy in thyroid nodules. Further studies are warranted to investigate the predictive role of increased vascularity in diagnosing suspicious thyroid nodules.
Authors: Jeffrey R Wienke; Wui K Chong; Julia R Fielding; Kelly H Zou; Carol A Mittelstaedt Journal: J Ultrasound Med Date: 2003-10 Impact factor: 2.153
Authors: David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle Journal: Thyroid Date: 2009-11 Impact factor: 6.568
Authors: J Matthew Debnam; Thinh Vu; Jia Sun; Wei Wei; Savitri Krishnamurthy; Mark E Zafereo; Steven P Weitzman; Naveen Garg; Salmaan Ahmed Journal: Gland Surg Date: 2019-10
Authors: M Shreyamsa; Anand Mishra; Pooja Ramakant; Anit Parihar; Kul R Singh; Chanchal Rana; Sasi Mouli Journal: Indian J Endocrinol Metab Date: 2021-01-12
Authors: Eun Ju Ha; Sae Rom Chung; Dong Gyu Na; Hye Shin Ahn; Jin Chung; Ji Ye Lee; Jeong Seon Park; Roh-Eul Yoo; Jung Hwan Baek; Sun Mi Baek; Seong Whi Cho; Yoon Jung Choi; Soo Yeon Hahn; So Lyung Jung; Ji-Hoon Kim; Seul Kee Kim; Soo Jin Kim; Chang Yoon Lee; Ho Kyu Lee; Jeong Hyun Lee; Young Hen Lee; Hyun Kyung Lim; Jung Hee Shin; Jung Suk Sim; Jin Young Sung; Jung Hyun Yoon; Miyoung Choi Journal: Korean J Radiol Date: 2021-10-26 Impact factor: 3.500
Authors: Thomas Studeny; Wolfgang Kratzer; Julian Schmidberger; Tilmann Graeter; Thomas F E Barth; Andreas Hillenbrand Journal: BMC Med Imaging Date: 2021-10-30 Impact factor: 1.930